Skip to main content

Genvor Inc

corporate_fare Company Profile

Genvor Inc

GNVR·OTC·Industrial Applications And Services·CIK 0001792941

Genvor Incorporated is a company focused on sustainable agriculture through AI-accelerated peptide technology. The company, originally named Allure Worldwide, Inc., changed its name to Genvor Incorporated on June 24, 2022. Its primary business operations are conducted through its wholly-owned subsidiary, Genvor Inc., which was incorporated in Delaware on April 4, 2019, initially as Nexion Biosciences Inc., and renamed Genvor Inc. on January 22, 2020. Genvor Inc. acquired Nexion Biosciences LLC (NBLLC) in May 2019; NBLLC was formed on December 28, 2018. The company completed the acquisition of Old Genvor on May 27, 2022, through a merger where Genvor Acquisition Corp., a wholly-owned subsidiary, merged with Old Genvor. As a result, 35,261,871 shares of Company common stock were issued to Old Genvor's pre-merger shareholders. Upon the closing of the acquisition, the Company had 55,261,871 issued and outstanding common shares, and its original founding shareholders subsequently cancelled 18,144,112 shares of Company common stock.

Genvor Inc (OTC:GNVR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 11 items for GNVR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-14, rated 8/10. Across its 11 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for GNVR spans 10-Q, DEF 14C, PRE 14C, 8-K.

Recent high-impact activity:

  • Genvor 10-Q Reveals $1.6M Tax Reimbursement Liability and New Material Weaknesses
  • Genvor Finalizes Sweeping Governance Overhaul and Equity Plan, Paving Way for Reverse Split
  • Genvor Inc. Majority Stockholders Greenlight Reverse Split, Equity Plan, and Sweeping Governance Overhaul
  • Genvor Secures $333K in Accelerated Funding, Issues Warrants at Double Current Price
  • Genvor Secures $333K in Funding, Doubles Warrant Coverage to 1.2M Shares

Financial Snapshot

Fiscal year ended September 30, 2025
Net Income
-$5.59M
Diluted EPS
-$0.22
Op. Cash Flow
-$555.72K
Operating Income
-$6.41M
Cash & Equivalents
$37.23K
Total Debt
$20K
Debt / Equity
-0.02×
Shares Outstanding
30.18M sh
Source: 10-K · filed 2025-12-10 · accession 0001903596-25-000575

Dilution Risk

Low risk

Filing-implied dilution signals for GNVR, detected from its recent SEC filings · based on capital-structure filings through 2026-05-13.

Substantial Doubt About Going Concern · Material Weaknesses in Internal Controls

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with G →
$0.69
52-week range · as of 2026-08-14 $0.000001 – $10.01
Market cap
$25.12M
Volume
100 (0.0× avg)
3-mo avg 5.7K
Live data · 2026-09-16 16:40 UTC · Market open

show_chartPrice Chart

Loading chart...

feed GNVR - Latest Insights

GNVR
Aug 14, 2026, 8:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.550
Real-time Price: $0.690 info
Change: Low Volume info
Market Cap: $25.123M info
GNVR
Jul 31, 2026, 4:15 PM EDT
Filing Type: DEF 14C
Importance Score:
8
Price at Filing: $0.497712
Real-time Price: $0.690 info
Change: Low Volume info
Market Cap: $25.123M info
GNVR
Jul 20, 2026, 5:20 PM EDT
Filing Type: PRE 14C
Importance Score:
8
Price at Filing: $0.4571
Real-time Price: $0.690 info
Change: Low Volume info
Market Cap: $25.123M info
GNVR
Jun 22, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.500
Real-time Price: $0.690 info
Change: Low Volume info
Market Cap: $25.123M info
GNVR
Jun 22, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.500
Real-time Price: $0.690 info
Change: Low Volume info
Market Cap: $25.123M info
GNVR
May 21, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.458132
Real-time Price: $0.690 info
Change: Low Volume info
Market Cap: $25.123M info
GNVR
May 13, 2026, 4:25 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.500
Real-time Price: $0.690 info
Change: Low Volume info
Market Cap: $25.123M info
GNVR
May 11, 2026, 5:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.500
Real-time Price: $0.690 info
Change: Low Volume info
Market Cap: $25.123M info
GNVR
Apr 22, 2026, 11:48 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.500
Real-time Price: $0.690 info
Change: Low Volume info
Market Cap: $25.123M info
GNVR
Apr 14, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.500
Real-time Price: $0.690 info
Change: Low Volume info
Market Cap: $25.123M info
GNVR
Feb 12, 2026, 10:17 AM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.02
Real-time Price: $0.690 info
Change: Low Volume info
Market Cap: $25.123M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets